Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9

by Jiangtao Ren, Yangbing Zhao
Published 2017-04-01

Increasing the safety and efficacy of chimeric antigen receptor T cell therapy

by Hua Li, Yangbing Zhao
Published 2017-04-01

Tim-4 in Health and Disease: Friend or Foe?

by Wen Liu, Liyun Xu, Liyun Xu, Xiaohong Liang, Xiaojun Liu, Yangbing Zhao, Yangbing Zhao, Chunhong Ma, Lifen Gao
Published 2020-04-01

Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation

by Xiaojun Liu, Shuguang Jiang, Chongyun Fang, Hua Li, Xuhua Zhang, Fuqin Zhang, Carl H. June, Yangbing Zhao
Published 2017-05-01

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18

by Biliang Hu, Jiangtao Ren, Yanping Luo, Brian Keith, Regina M. Young, John Scholler, Yangbing Zhao, Carl H. June
Published 2017-09-01

iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificity

by Christopher L. Nobles, Shantan Reddy, January Salas-McKee, Xiaojun Liu, Carl H. June, J. Joseph Melenhorst, Megan M. Davis, Yangbing Zhao, Frederic D. Bushman
Published 2019-01-01